Received: 7 June 2020
Accepted: 8 September 2020
First Online: 16 September 2020
Ethics approval and consent to participate
: The study was performed as part of the routine work of the National Center for Antibiotic Resistance and Infection Control, Ministry of Health. No ethics approval or participant consent was required for this study using de-identified isolates.
: No human subjects were involved in this study.
: Y.C. has received research funding/personal fees from MSD, AstraZeneca, Allecra Therapeutics, DaVoltera, bioMérieux SA, Nariva, Achoagen, Roche, Pfizer, Shionogi, VenatoRx and Qpex Pharmaceuticals. Funders have no role in conducting this research. All authors report no potential conflicts of interest with respect to the research, authorship, and publication of this article.